Skip to main content

Table 1 Patient’s characteristics and indications for [99mTc]Tc-PSMA-I&S-SPECT/CT

From: [99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center

 NAge [years]Mean PSA [ng/ml]
Total21073 (± 8.5)50 (± 270)
Indications
 biochemical recurrence (BCR)152 (72.4%)72.8 (± 8.8)8.7 (± 32)
 primary staging in high-risk PCa12 (5.7%)72.7 (± 8.6)393 (± 982)
 restaging in advanced recurrent PCa (antiandrogen therapy, chemotherapy, radiation therapy, 177Lu-PSMA therapy)46 (21.9%)74.2 (± 8.1)101.3 (± 242)